In the ongoing battle against cardiovascular disease—the leading cause of mortality globally—the ability to identify asymptomatic patients before a catastrophic event occurs remains the "Holy Grail" of preventative medicine. A groundbreaking study published today in the Journal of the American Heart Association (JAHA) suggests that the clinical community may have found a more potent tool to achieve this goal.
The research indicates that the PREVENT™ (Predicting Risk of cardiovascular disease EVENTs) risk calculator, introduced by the American Heart Association (AHA) in 2023, is not merely a theoretical exercise in probability. When deployed alongside coronary artery calcium (CAC) scoring, the tool demonstrates a remarkable capacity to identify hidden arterial plaque and predict future heart attacks with high precision. By marrying demographic and physiological data with advanced medical imaging, clinicians may soon have a more robust roadmap for tailoring life-saving interventions.
The Genesis of PREVENT™: A Paradigm Shift in Risk Assessment
To understand the significance of this new research, one must first understand the tool itself. The PREVENT™ risk calculator represents a departure from traditional cardiovascular risk assessment models. While older models often relied on a narrow set of metrics—primarily blood pressure and cholesterol levels—PREVENT™ takes a holistic, multidimensional approach to patient health.
Released by the AHA as part of its Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health, the calculator is designed for adults as young as 30. It integrates a wide array of variables:
- Biological Markers: Age, cholesterol levels, blood pressure, and kidney function.
- Metabolic Health: Body Mass Index (BMI) and Type 2 diabetes status.
- Lifestyle & Environment: Smoking history and social determinants of health (SDOH).
By incorporating these factors, the calculator estimates the 10-year and 30-year risk of heart attack, stroke, and heart failure. However, until this study, the real-world correlation between these calculated scores and the physical reality of arterial plaque buildup remained a subject of clinical investigation.
Methodology: Mining Real-World Data
The study conducted by researchers at NYU Grossman School of Medicine sought to validate the calculator’s efficacy by testing it against the "gold standard" of non-invasive imaging: the coronary computed tomography angiography (CCTA).
The researchers analyzed electronic health records for nearly 7,000 adults who underwent CCTA screening at NYU Langone Health between 2010 and 2024. The objective was two-fold:
- To determine if the PREVENT™ score accurately mirrored the level of calcium buildup detected in the coronary arteries.
- To assess whether combining the PREVENT™ score with CAC scores yielded a more accurate prediction of future cardiovascular events than either metric used in isolation.
The results were striking. The study found that individuals identified by the PREVENT™ calculator as being at the highest risk consistently aligned with the group that experienced actual heart attacks during the follow-up period. This suggests that the calculator is not just a statistical model but a reliable proxy for the physical state of a patient’s cardiovascular system.
The Role of Coronary Artery Calcium (CAC) Scoring
If PREVENT™ is the "map," the CAC score is the "ground truth." Coronary artery calcium scoring is a non-invasive imaging test that visualizes calcified plaque—the "hard" evidence of atherosclerosis—within the heart’s arteries.
For patients and physicians, the CAC score acts as a definitive decision-support tool. If a patient is hesitant to begin a lifelong regimen of statins or other lipid-lowering therapies, the visual evidence of calcium buildup often serves as the catalyst for change. The new JAHA study underscores that when these two tools are combined—the predictive power of PREVENT™ and the diagnostic clarity of the CAC score—physicians can move from "guessing" to "precision treating."
Expert Perspectives: Tailoring the Path to Prevention
Dr. Morgan Grams, the corresponding author of the study and the Susan and Morris Mark Professor of Medicine and Population Health at NYU Grossman School of Medicine, emphasized the clinical necessity of these findings.
"These findings are important because when we can better predict a patient’s risk of heart attack, we can also tailor care and determine who may benefit from treatment to prevent a heart attack, such as cholesterol-lowering medications," Dr. Grams stated. She further highlighted that the study’s reliance on real-world data—rather than a sanitized clinical trial environment—makes the results particularly actionable for everyday practice. "The findings illustrate that PREVENT is accurate in identifying people who may have subclinical risk for cardiovascular disease, meaning blocked arteries before symptoms develop."
Dr. Sadiya Khan, a co-author of the study and a volunteer expert for the American Heart Association, elaborated on the utility of the CAC score in clinical decision-making. Having chaired the writing group for the 2023 Scientific Statement on PREVENT™, Dr. Khan is intimately familiar with the need for better diagnostic stratification.
"CT scans to evaluate for coronary calcium and the extent of coronary artery calcium buildup may be useful when patients are uncertain if they want to start lipid-lowering therapy or if lipid-lowering therapy should be intensified," Dr. Khan noted. "We have so many tools in our armamentarium for reducing the risk of heart attack; we want to be able to optimize treatments for patients, especially those at higher risk."
Implications for Future Guidelines
The implications of this research are significant for the medical community. Current clinical guidelines often struggle with the "intermediate risk" category—patients who do not clearly fall into low-risk or high-risk buckets. By demonstrating that PREVENT™ effectively identifies subclinical disease, the researchers have provided a framework that could be integrated into future standard-of-care guidelines.
Furthermore, the integration of social determinants of health into the PREVENT™ calculator marks a major step toward addressing health inequities. By accounting for the environmental and social factors that influence cardiovascular health, the calculator provides a more inclusive view of risk, potentially helping to close the gap in outcomes for underserved populations.
Critical Analysis and Limitations
While the study offers a compelling case for the use of the PREVENT™ calculator, the authors were careful to acknowledge its limitations, ensuring that the scientific community views these results within their proper context:
- Geographic and Demographic Homogeneity: The study was limited to a single institution (NYU Langone), and the majority of participants were white. This raises questions about the generalizability of the findings to more diverse populations, where socioeconomic and environmental factors may differ significantly.
- Data Source Constraints: Relying solely on electronic health records can introduce biases, as these records may be incomplete or capture varying levels of detail depending on the provider.
- Short Follow-up Duration: With a follow-up period of only 1.2 years, the study captures short-term events but cannot speak to the long-term, decade-spanning accuracy of the calculator.
- The "Non-Calcified" Gap: The study did not assess non-calcified plaque. This is a critical omission, as soft, non-calcified plaque can be just as dangerous—if not more so—than the calcified plaque detected by the CAC score.
- Referral Bias: Because the participants were already referred for CCTA/CAC screening by a physician, they likely possessed more risk factors than the general population. This could lead to an overestimation of the prevalence of coronary artery calcium in the broader, healthier population.
Moving Toward a Heart-Healthy Future
Despite these limitations, the study represents a vital step forward. The medical community is moving away from a "one-size-fits-all" approach to heart health and toward a personalized, data-driven model. By leveraging the computational strength of the PREVENT™ calculator alongside the diagnostic precision of coronary imaging, physicians can provide a more nuanced risk assessment.
For the patient, this means the possibility of catching disease at the "subclinical" stage—when arteries are beginning to clog, but before the life-altering impact of a heart attack occurs. As the American Heart Association continues to refine the PREVENT™ framework, the hope is that these tools will empower both patients and providers to intervene earlier, more accurately, and more effectively.
In the final analysis, the research confirms what many in the field have long suspected: that the key to preventing the "event" lies in the ability to predict it with accuracy. With the PREVENT™ calculator and modern imaging techniques, that goal is closer to reality than ever before.
